Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Clinical Trial1
- Clinical Study1
- Comparative Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- S Afr Med J1
Search Results
Sort by
year (new to old)
- BookContents:
Case Interviewsat a Glance
Case Interview Primer
The WetFeet Way
Case Interview Prep
The Recruiter's Perspective
Case Examples
Additional Resources.Digital Access ProQuest Ebook Central ©2008Limited to 1 simultaneous users - ArticleKing JB, Kalk WJ, Vinik AI, Jackson WP, Bracher M, Jacobs P.S Afr Med J. 1977 Jan 29;51(5):124-6.The effect of the sulphonylureas gliclazide (S 852) and glibenese on platelet function, blood lipid levels and the control of diabetes, was prospectively evaluated in 12 maturity-onset diabetic subjects by means of a double-blind crossover study. Including the pretrial period, platelet aggregation in response to collagen was uniformly lower than in matched normal controls, but neither drug produced any additional effect on platelet function. Control of blood glucose levels was no better than with comparable agents, and no measurable changes occurred in blood lipid levels. The drugs had no significant side-effects and were well tolerated. It is concluded that neither agent offers special advantages over other sulphonylureas, particularly in regard to platelet function.